Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Karolina Tecza
Pharmacogenetics of Toxicity of 5-Fluorouracil, Doxorubicin and Cyclophosphamide Chemotherapy in Breast Cancer Patients
Oncotarget
Oncology
Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy
Hereditary Cancer in Clinical Practice
Oncology
Genetics
Related publications
Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Mobilization of Peripheral Blood Progenitor Cells After Induction Chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and Granulocyte Colony-Stimulating Factor in Breast Cancer
Bone Marrow Transplantation
Transplantation
Hematology
Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy
Clinical Cancer Research
Cancer Research
Oncology
Insulin-Induced Enhancement of McF-7 Breast Cancer Cell Response to 5-Fluorouracil and Cyclophosphamide
Tumor Biology
Medicine
Cancer Research
High Dose, Dose-Intensive Chemotherapy With Doxorubicin and Cyclophosphamide for the Treatment of Advanced Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Sequential Methotrexate and 5-Fluorouracil, Doxorubicin, and Cisplatin for Advanced Urothelial Cancer
Japanese Journal of Urology
Urology
Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)
Scientific Reports
Multidisciplinary
Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer
New England Journal of Medicine
Medicine
